Press Releases

Month Year

Month Year

May 10, 2011

Insmed Announces First Quarter 2011 Financial Results

Insmed Announces First Quarter 2011 Financial Results

Read more
Apr 26, 2011

Insmed to Host 2011 First Quarter Earnings Conference Call

Insmed to Host 2011 First Quarter Earnings Conference Call

Read more
Mar 21, 2011

Insmed Regains NASDAQ Compliance

Read more
Mar 21, 2011

Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication

Read more
Mar 10, 2011

Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results

Read more
Mar 3, 2011

Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication

Read more
Mar 2, 2011

One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective

Read more
Mar 1, 2011

Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split

Read more
Feb 24, 2011

Insmed to Participate on Phase III and Beyond Panel at 2011 RBC Capital Markets Healthcare Conference

Read more
Feb 23, 2011

Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation